In Vitro and Ex Vivo Kinetic Release Profile of Growth Factors and Cytokines from Leucocyte- and Platelet-Rich Fibrin (L-PRF) Preparations

L-PRF is an autologous blood-derived biomaterial (ABDB) capable of releasing biologically active agents to promote healing. Little is known about its release profile of growth factors (GFs), cytokines, and MMPs. This study reported the in vitro and ex vivo release kinetics of GFs, cytokines, and MMPs from L-PRF at 6, 24, 72, and 168 h. The in vitro release rates of PDGF, TGF-β1, EGF, FGF-2, VEGF, and MMPs decreased over time with different rates, while those of IL-1β, IL-6, TNF-α, IL-8, and IL-10 were low at 6 h and then increased rapidly for up to 24 h and subsequently decreased. Of note, the release rates of the GFs followed first-order kinetics both in vitro and ex vivo. Higher rates of release were found ex vivo, suggesting that significant amounts of GFs were produced by the local cells within the wound. In addition, the half-life times of GFs locally produced in the wound, including PDGF-AA, PDGF-AB/BB, and VEGF, were significantly extended (p < 0.05). This work demonstrates that L-PRF can sustain the release of GFs and cytokines for up to 7 days, and it shows that the former can activate cells to produce additional mediators and amplify the communication network for optimizing the wound environment, thereby enhancing healing.

[1]  Xuzhu Wang,et al.  Increased local concentrations of growth factors from leucocyte- and platelet-rich fibrin do not translate into improved alveolar ridge preservation: an intraindividual mechanistic randomized controlled trial. , 2022, Journal of clinical periodontology.

[2]  Q. Wan,et al.  Effects of platelet concentrates on implant stability and marginal bone loss: a systematic review and meta-analysis , 2021, BMC Oral Health.

[3]  Yong-Beom Park,et al.  Adverse Reactions and Clinical Outcomes for Leukocyte-Poor Versus Leukocyte-Rich Platelet-Rich Plasma in Knee Osteoarthritis: A Systematic Review and Meta-analysis , 2021, Orthopaedic journal of sports medicine.

[4]  Ning Li,et al.  Novel applications of platelet concentrates in tissue regeneration (Review) , 2021, Experimental and therapeutic medicine.

[5]  M. Fabbro,et al.  Effectiveness of Autologous Platelet Concentrates in Management of Young Immature Necrotic Permanent Teeth—A Systematic Review and Meta-Analysis , 2020, Cells.

[6]  A. Alshatwi,et al.  Cytokine Expression Pattern and Protein-Protein interaction network analysis of Leucocyte Rich Platelet Rich Fibrin and Injectable Form of Platelet Rich Fibrin , 2020, Oral and Maxillofacial Surgery.

[7]  Shravanthy Ravi,et al.  Mechanical, chemical, structural analysis and comparative release of PDGF-AA from L-PRF, A-PRF and T-PRF - an in vitro study , 2020, Biomaterials Research.

[8]  M. Riminucci,et al.  Postextractive Alveolar Ridge Preservation Using L-PRF: Clinical and Histological Evaluation , 2020, Case reports in dentistry.

[9]  P. Coelho,et al.  The effect of platelet-rich fibrin exudate addition to porous poly(lactic-co-glycolic acid) scaffold in bone healing: An in vivo study. , 2020, Journal of biomedical materials research. Part B, Applied biomaterials.

[10]  S. Taschieri,et al.  Autologous Platelet Concentrates in Treatment of Furcation Defects—A Systematic Review and Meta-Analysis , 2019, International journal of molecular sciences.

[11]  C. M. Figueredo,et al.  Platelet-rich fibrin in oral surgical procedures: a systematic review and meta-analysis. , 2019, International journal of oral and maxillofacial surgery.

[12]  W. Teughels,et al.  Characterization of the Leukocyte- and Platelet-Rich Fibrin Block: Release of Growth Factors, Cellular Content, and Structure. , 2019, The International journal of oral & maxillofacial implants.

[13]  S. Ghanaati,et al.  Fifteen Years of Platelet Rich Fibrin in Dentistry and Oromaxillofacial Surgery: How High is the Level of Scientific Evidence? , 2018, The Journal of oral implantology.

[14]  R. Miron,et al.  The effect of age, gender, and time between blood draw and start of centrifugation on the size outcomes of platelet-rich fibrin (PRF) membranes , 2018, Clinical Oral Investigations.

[15]  M. Quirynen,et al.  The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane , 2018, Platelets.

[16]  H. Redl,et al.  Fibrin‐based delivery strategies for acute and chronic wound healing , 2017, Advanced drug delivery reviews.

[17]  S. Ghanaati,et al.  Use of platelet-rich fibrin in regenerative dentistry: a systematic review , 2017, Clinical Oral Investigations.

[18]  S. Ghanaati,et al.  Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? , 2017, Clinical Oral Investigations.

[19]  W. Teughels,et al.  The use of leucocyte and platelet-rich fibrin in socket management and ridge preservation: a split-mouth, randomized, controlled clinical trial. , 2016, Journal of clinical periodontology.

[20]  A. Chatterjee,et al.  Fibrin network pattern changes of platelet-rich fibrin in young versus old age group of individuals: A cell block cytology study , 2016, Journal of Indian Society of Periodontology.

[21]  H. Atmaca,et al.  Effect of centrifugation time on growth factor and MMP release of an experimental platelet-rich fibrin-type product , 2016, Platelets.

[22]  R. Miron,et al.  Comparative release of growth factors from PRP, PRF, and advanced-PRF , 2016, Clinical Oral Investigations.

[23]  M. Alini,et al.  Enhancing inflammatory and chemotactic signals to regulate bone regeneration. , 2014, European cells & materials.

[24]  O. Stojadinović,et al.  Clinical application of growth factors and cytokines in wound healing , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[25]  J. P. McCoy,et al.  Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. , 2012, Cytokine.

[26]  K. Lu,et al.  Platelet-rich fibrin increases cell attachment, proliferation and collagen-related protein expression of human osteoblasts. , 2012, Australian dental journal.

[27]  J. Folkman,et al.  Normal ranges of angiogenesis regulatory proteins in human platelets , 2010, American journal of hematology.

[28]  D. M. Dohan Ehrenfest,et al.  Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies , 2009, Growth factors.

[29]  S. Turco,et al.  A simple model based on first order kinetics to explain release of highly water soluble drugs from porous dicalcium phosphate dihydrate matrices , 1995 .

[30]  D. S. Snyder,et al.  Human serum and plasma have different sources of epidermal growth factor. , 1990, The American journal of physiology.